Cutis marmorata telangiectatica congenita (CMTC) is a rare vascular condition characterized by a distinctive pattern of skin discoloration and dilated blood vessels. It typically presents at birth or shortly after and affects the skin on various parts of the body, most commonly the limbs and trunk. The affected skin appears mottled or marbled, resembling a net-like pattern, hence the name "cutis marmorata." The condition is caused by abnormalities in the development of blood vessels, leading to poor blood flow and resulting in the visible skin changes.
CMTC is usually benign and does not cause any significant health problems. However, in some cases, it may be associated with other abnormalities, such as limb length discrepancies or developmental delays. The exact cause of CMTC is unknown, and it is believed to occur sporadically without a clear genetic or hereditary basis.
While there is no specific treatment for CMTC, management focuses on addressing any associated complications and providing supportive care. Regular monitoring by healthcare professionals is recommended to ensure proper growth and development. It is important to consult with a healthcare provider for an accurate diagnosis and appropriate management of CMTC.